Menu

Recovering Lost Memories

Researchers use optogenetics to induce recall in an Alzheimer’s mouse model, suggesting the disease may not destroy memories permanently.

Mar 21, 2016
Jef Akst

FLICKR, DAY DONALDSONMice genetically engineered to exhibit Alzheimer’s disease-like symptoms quickly forget a learned association between an environment and a painful stimulus, such as a foot shock. But using light to stimulate cells of the hippocampus, where short-term memories are encoded, MIT’s Susumu Tonegawa and colleagues could seemingly reinstate the environment-triggered fear in those forgetful mice, according to a study published last week (March 16) in Nature.

“Even if a memory seems to be gone, it is still there,” Tonegawa told The Washington Post. “It’s a matter of how to retrieve it.” The researchers speculate that the neural stimulation prompted the hippocampal neurons to regrow dendritic spines and reestablish connections with other neurons.

The findings have “shattered a 20-year paradigm of how we’re thinking about the disease,” Harvard neurology professor Rudy Tanzi, who was not involved in the research, told the Boston Herald.

While the optogenetic technique used in the study cannot be immediately translated to humans, deep-brain stimulation may one day serve as a viable alternative, Columbia University neurobiologist Christine Denny told The Washington Post.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.